The arrangement is analogous to the emergency use authorization that the drug received from the FDA earlier this month. Peer-reviewed data from the Phase III NIAID study of the drug were published Friday.
The deal will make the Phase III drug inclisiran - which Novartis acquired when it bought The Medicines Company in November - available to patients in the U.K. and include manufacturing and clinical development efforts.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The NHS pitches the service as being especially useful to elderly patients, blind patients and those who cannot access the internet through traditional means.
NHS said it hopes to make England the first country to eliminate HCV. The effort will involve finding people living with the virus and providing drugs procured from AbbVie, Gilead and Merck.
NICE recommends Kymriah to the Cancer Drugs Fund due to remaining questions about evidence to support it, but believes those questions will be resolved.
Remember the ransomware attack that started last Friday? It hasn't stopped spreading. And HHS is encouraging hospitals across the United States to proceed with caution.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
An enormous ransomware attack has impacted organizations across the globe, including the National Health Service. U.K. hospitals resorted to diverting patients and using pen and paper for documentation.
Bruin Biometrics is connecting its wireless pressure ulcer detector, the SEM Scanner, to a digital registry for pressure ulcers known as PUNT (Pressure Ulcer Notification Tool).
Plus, Caitlyn Jenner advocates for transgender health, physicians fight burnout and AI system proves highly accurate in detecting cancerous cells.
AliveCor Founder and CMO Dr. Dave Albert said that this opens the door to the NHS buying AliveCor devices for all 2 million atrial fibrillation patients in England "to save money and lives by preventing strokes."
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
"This will include information about people who are HIV-positive, for instance, as well as details of drug overdoses and abortions. The agreement also includes access to patient data from the last five years," according to New Scientist.
The plan includes hiring patient safety guru Dr. Robert Wachter of the University of California, San Francisco, to review IT infrastructure across the NHS.
Few industries still rely on fax technology the way healthcare does, and advocates for greater transparency in healthcare on both sides of the Atlantic can't wait for that to change.
The National Health Service in England has come out with a very cool infographic that helps explain risk to patients. The NHS Atlas of Risk puts conditions or situations into perspective – comparing the likelihood to die from murder to, say, a lack of sufficient fruits and vegetables in one’s diet. As far as risk analysis runs […]
In England, consultants uploaded the country's entire healthcare dataset – inpatient, outpatient and emergency room records - to Google servers outside Britian.